Evidence map›Paper›PMID 33431896›Full record

ArticleNature communications2021

Small molecule targeting r(UGGAA)

Tomonori Shibata, Konami Nagano, Morio Ueyama, Kensuke Ninomiya, Tetsuro Hirose, Yoshitaka Nagai, Kinya Ishikawa, Gota Kawai, Kazuhiko Nakatani

Abstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Small molecule approaches to targeting RNA.Nature reviews. Chemistry · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. ArcRNAs and the formation of nuclear bodies.Mammalian genome : official journal of the International Mammalian Genome Society · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tomonori ShibataDepartment of Regulatory Bioorganic Chemistry, The Institute of Scientific and Industrial Research (ISIR), Osaka University, Ibaraki, Japan.
Konami NaganoDepartment of Life and Environmental Sciences, Faculty of Engineering, Chiba Institute of Technology, Chiba, Japan.
Morio UeyamaDepartment of Neurotherapeutics, Osaka University Graduate School of Medicine, Suita, Japan.ORCID 0000-0002-2950-7361
Kensuke NinomiyaGraduate School of Frontier Biosciences, Osaka University, Suita, Japan.
Tetsuro HiroseGraduate School of Frontier Biosciences, Osaka University, Suita, Japan.ORCID 0000-0003-1068-5464
Yoshitaka NagaiDepartment of Neurotherapeutics, Osaka University Graduate School of Medicine, Suita, Japan.ORCID 0000-0003-1037-3129
Kinya IshikawaCenter for Personalized Medicine for Healthy Aging, Tokyo Medical and Dental University, Tokyo, Japan.
Gota KawaiDepartment of Life and Environmental Sciences, Faculty of Engineering, Chiba Institute of Technology, Chiba, Japan.ORCID 0000-0003-1480-2840
Kazuhiko NakataniDepartment of Regulatory Bioorganic Chemistry, The Institute of Scientific and Industrial Research (ISIR), Osaka University, Ibaraki, Japan. nakatani@sanken.osaka-u.ac.jp.ORCID 0000-0002-1705-5265

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synthetic small molecules modulating RNA structure and function have therapeutic potential for RNA diseases. Here we report our discovery that naphthyridine carbamate dimer (NCD) targets disease-causing r(UGGAA)

Indexed as

AnimalsBase SequenceCell NucleusDisease Models, AnimalDrosophilaHeLa CellsHumansIntronsMagnetic Resonance SpectroscopyModels, MolecularNucleic Acid ConformationPhenotypePhosphorylationRNARNA-Binding ProteinsSmall Molecule LibrariesRNARNA-Binding ProteinsSmall Molecule Libraries

Identifiers

PMID33431896
PMCPMC7801683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.